Can Wang

Can Wang practices at Corewell Health Farmington Hills Hospital in Farmington Hills, Michigan, part of Corewell Health.

Can Wang's NPI, 1952806259, was assigned on March 28, 2018. Can Wang holds New Hampshire license 32070.

Can Wang's primary practice is Corewell Health Farmington Hills Hospital, at 28050 Grand River Avenue, Farmington Hills, MI 48336 in Oakland County. The practice phone is (248) 471-8000.

Can Wang's primary practice is Corewell Health Farmington Hills Hospital in Farmington Hills, Michigan, part of Corewell Health. Can Wang is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Can Wang to 1 more hospital, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Can Wang practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Can Wang's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Can Wang is licensed in New Hampshire.

CMS data shows 83 Medicare services from Can Wang across 2 procedure codes in 2024, all of them office visits, for 73 Medicare patients. Medicare paid $8,353 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Can Wang in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Can Wang's median patient age at 65, with 54% women.

In 2024, Can Wang wrote 89 Medicare Part D claims for 24 patients. 80% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $170 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Can Wang for performance year 2024, reported through an alternative payment model (APM). Can Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Can Wang as offering telehealth.

Dmand AI links 4 papers to Can Wang, published from 2020 to 2023. 2020 was the busiest year, with 2. Can Wang's most frequent co-authors are John-Ross David Rolphe Clarke, MD, Ashimiyu Babatunde Durojaiye, MD and Shahrukh K. Hashmi, MD.

CMS Open Payments shows 2 general payments to Can Wang from 2 drug and device companies from 2023 to 2024. Education make up the largest share, 79% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $85.